11 Results for "

systemic vascular resistance

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "systemic vascular resistance" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-12717
CAS No.: 50-60-2
Purity:  99.94%
Target:  

Adrenergic Receptor

Phentolamine is an orally active, selective α1 and α2 Adrenergic receptor antagonist. Phentolamine antagonizes the vasodilatory effect of Cromakalim (HY-110011) on isolated circumflex coronary artery segments in dogs. Phentolamine reduces systemic vascular resistance and increases cardiac output. Phentolamine improves erectile dysfunction. Phentolamine can be used for the research of erectile dysfunction .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-12717A
CAS No.: 73-05-2
Purity:  99.87%
Target:  

Adrenergic Receptor

Phentolamine hydrochloride is an orally active, selective α1 and α2 Adrenergic receptor antagonist. Phentolamine hydrochloride antagonizes the vasodilatory effect of Cromakalim (HY-110011) on isolated circumflex coronary artery segments in dogs. Phentolamine hydrochloride reduces systemic vascular resistance and increases cardiac output. Phentolamine hydrochloride improves erectile dysfunction. Phentolamine hydrochloride can be used for the research of erectile dysfunction .
loading...
    loading...
Cat. No.: HY-106690
CAS No.: 57961-90-7
Purity:  99.87%
Synonyms: Centhaquine; PMZ-2010
Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models .
loading...
    loading...
Cat. No.: HY-N7065
CAS No.: 7327-87-9
Dihydralazine sulfate is an antihypertensive hydrazine derivative and also a low-potency genotoxic agent. Dihydralazine sulfate is a direct-acting mutagen with a mixed gene mutation mechanism, which induces DNA fragmentation in the lung, kidney and spleen of mice, and induces sister chromatid exchange in mouse bone marrow cells. Dihydralazine sulfate specifically kills DNA repair-deficient bacteria. Dihydralazine sulfate is a vasodilator and antihypertensive agent that reduces systemic vascular resistance, increases cardiac output and heart rate, thereby lowering blood pressure. Dihydralazine sulfate can be used in research related to hypertension and severe early-onset preeclampsia .
loading...
    loading...
Cat. No.: HY-119817
CAS No.: 76568-02-0
Synonyms: BTS 49465; Flosequinon
Target:  

PKC

Research Areas:  

Cardiovascular Disease

Flosequinan is a balanced vasodilator. Flosequinan not only significantly reduces systemic vascular resistance, but also significantly reduces the beating component of left ventricular afterload, characteristic impedance and arterial wave reflection, which can be used in the research of acute heart failure .
loading...
    loading...
Cat. No.: HY-106690R
CAS No.: 57961-90-7
Target:  

Others

Centhaquin (Standard) is the analytical standard of Centhaquin. This product is intended for research and analytical applications. Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models .
loading...
    loading...
Cat. No.: HY-B1660
CAS No.: 22195-34-2
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Guanadrel sulfate is an orally active, potent and postganglionic sympathetic inhibitor. Guanadrel sulfate lowers blood pressure by reducing systemic vascular resistance with little effect on cardiac output. Guanadrel sulfate is promising for research of hypertension .
loading...
    loading...
Cat. No.: HY-118765
CAS No.: 110996-51-5
Research Areas:  

Cardiovascular Disease

Ro 23-3423 is a thromboxane synthase inhibitor with an IC50 value of 0.33 μM for human platelet microsomal thromboxane synthase. Ro 23-3423 increases plasma levels of PGF and PGE2 in a dose-dependent manner, accompanied by a decrease in mean systemic arterial pressure and systemic vascular resistance. Ro 23-3423 can be used in the study of general anesthesia .
loading...
    loading...
Cat. No.: HY-126401
CAS No.: 119413-55-7
Synonyms: IQB-875 free base
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease

Elgodipine (IQB-875 free base) is an orally active dihydropyridine calcium antagonist and an antianginal compound. Elgodipine inhibits both T- and L-type calcium channels (IC50: 32 and 2.3 nM). Elgodipine lowers systemic vascular resistance and improves systolic cardiac function .
loading...
    loading...
Cat. No.: HY-W746271
CAS No.: 142304-17-4
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

TCV 295 is an orally active potassium channel opener. TCV 295 can reduce blood pressure, systemic vascular resistance and myocardial O2 consumption. TCV 295 can be used for the research of cardiovascular disease, such as hypertension .
loading...
    loading...
Cat. No.: HY-N7065R
CAS No.: 7327-87-9
Dihydralazine sulfate (Standard) is the analytical standard of Dihydralazine sulfate (HY-N7065). This product is intended for research and analytical applications. Dihydralazine sulfate is an antihypertensive hydrazine derivative and also a low-potency genotoxic agent. Dihydralazine sulfate is a direct-acting mutagen with a mixed gene mutation mechanism, which induces DNA fragmentation in the lung, kidney and spleen of mice, and induces sister chromatid exchange in mouse bone marrow cells. Dihydralazine sulfate specifically kills DNA repair-deficient bacteria. Dihydralazine sulfate is a vasodilator and antihypertensive agent that reduces systemic vascular resistance, increases cardiac output and heart rate, thereby lowering blood pressure. Dihydralazine sulfate can be used in research related to hypertension and severe early-onset preeclampsia .
loading...
    loading...
  • 1